• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

To Engage and Activate Patients, CRM Alone Isn’t Enough

Share:

March 15, 2022

We talk about patient engagement a lot in healthcare today. But the reality is, we often don’t just want a patient to engage with a piece of content or information; we want them to take action. The traditional CRM and marketing automation are great tools for the former – keeping patients and their healthcare providers connected. But it does little to move beyond a digital connection.

Today’s patients (or, consumers) expect more from all of their relationships, especially their healthcare providers. And, health systems have a need to drive loyalty, revenue, and improved health outcomes.

To achieve that, systems need to take their CRM strategy to the next level: CRM Intelligence. Combining data and AI can take patient engagement to the next level: patient activation.

When the right patients receive the right communication at the right time, they do something that moves them further along their healthcare journey; whether that’s scheduling a screening or an annual wellness visit (AWV), the patient becomes actively engaged.

Patient activation as a top concern

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Recent research sought to understand the priorities of mid -to -large-size health systems; the resounding answer from patient outreach and communication teams: patient activation. With the growing presence of retail health clinics, direct-to-consumer (D2C) healthcare brands, and the decline of the traditional provider-patient relationship, health systems highlighted the need to deliver relevance and value at every touchpoint.

Engagement alone is no longer enough. Engagement that leads to activation is critical to keep systems competitive and patients healthy.

Traditional CRM systems fail to deliver insights

Health systems are swimming in data; so much that healthcare executives often talk about “data overload” or “data paralysis.” Traditional non-AI-powered CRMs help organize this data, which can be a welcome benefit when volume and complexity are so high. But that’s where they stop.

They don’t offer automated guidance or insight on a prioritized list of the next best actions for the patient based on that data. Doing this at scale can be a game-changer for both health systems and their patients.

Artificial intelligence enables patient activation

For health systems, AI models can enable a hyper-targeted, one-to-one approach to patient outreach. To do so, they can connect and train on a health organization’s existing data sources to determine which patients to engage, for which services, and through which channels. Unlike a traditional CRM, CRM Intelligence detects correlations between rows and columns of patient data to prioritize – and predict – the most relevant action(s) for each patient.

Intelligence-based outreach efforts yield measurable results

Early in the COVID-19 pandemic, one East Coast-based health system wanted to let patients know it was safe to come back – and ensure the patients who needed care most were first through the doors.

So, they started with breast cancer.

With AI modeling, they went far beyond demographics and patient history, to probe multidimensional EHR, payer, claims, and third-party datasets and observe millions of local population encounters to identify patients who were up to 15x more likely to have breast cancer vs. the general population. Then, they developed customized communication journeys for each individual, digitally engaging patients with personalized content via their preferred channels of communication.

From March 2020 through May 2021, 11,310 mammograms were scheduled. As a result, 1,395 breast cancer diagnoses were made in patients who may have otherwise postponed screening due to pandemic-related fears.

Changing healthcare consumer expectations require new engagement strategies

An estimated 10 million cancer screenings were missed during the first months of the pandemic alone, which is having a negative downstream impact on people’s health and overall cancer outcomes. While these were extraordinary times as a result of a global pandemic, the reality is, to get people to make these important preventive care appointments, health systems and providers need to be more proactive, relevant, and timely in their outreach. Ensuring a message about scheduling a colonoscopy reaches someone at highest risk for colon cancer has a much higher likelihood of that patient scheduling – and showing up for – an appointment.

Every patient is a consumer, and they have become accustomed to receiving messages that are tailored and customized to their habits, history, and needs. Now they are shifting the expectations for that same kind of content and engagement to healthcare.

Today, that shift represents a mostly untapped opportunity for health systems and providers to connect more effectively, proactively, and intelligently with patients. Doing so not only presents new revenue opportunities and competitive advantage but can improve patients’ overall health and health outcomes.

The combination of AI and data represents a game-changer for health systems – the move away from one-way engagement and towards meaningful patient activation.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Blue Sprig Pediatrics Announces Acquisition Of Thrive Autism SolutionsBlue Sprig Pediatrics Announces Acquisition Of Thrive Autism Solutions
  • Shire : Takeda`s proposed takeover of Shire receives conditional EU clearanceShire : Takeda`s proposed takeover of Shire receives conditional EU clearance
  • ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical ResearchICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research
  • Notable Launches End-to-End Revenue Cycle Workflow Automation SolutionNotable Launches End-to-End Revenue Cycle Workflow Automation Solution
  • Neptune Closes SugarLeaf Acquisition, Expanding U.S. Extraction CapabilitiesNeptune Closes SugarLeaf Acquisition, Expanding U.S. Extraction Capabilities
  • Trimb Closes its Acquisition of Skin Care Brands in Northern EuropeTrimb Closes its Acquisition of Skin Care Brands in Northern Europe
  • American Medical Technologies Announces Acquisition by One Equity Partners and The Silverfern GroupAmerican Medical Technologies Announces Acquisition by One Equity Partners and The Silverfern Group
  • Global Pharmaceutical Pricing and Reimbursement Markets 2014-2024 – ResearchAndMarkets.comGlobal Pharmaceutical Pricing and Reimbursement Markets 2014-2024 – ResearchAndMarkets.com

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications